Tel: +44(0)20 7691 0984 Email: contact@transpharmation.co.uk Newsletter Sign Up
  • CEO Mark Duxon interviewed by The Pharma Letter on impact of Brexit on CROs...
  • Announcing new premises in Poland with a focus on neuropsychiatric disorders...
  • State-of-the-art premises opening this month at Discovery Park in Kent...
  • Newly published work in Frontiers in Psychiatry demonstrating
  • the effectiveness of a clinically relevant dose of ketamine...
  • Head to 2021 conferences page to see titles of abstracts...
 

Conferences

All the latest conference updates; those that we are attending and the studies that we are presenting

With preclinical – clinical transition being the largest failure risk in CNS therapeutics development, join us at hubXchange’s CNS Therapeutics East Coast Virtual roundtable meeting, where senior drug developers from pharma and biotech share experiences and discuss the future research landscape. Transpharmation has a presentation slot

For more information on the speaker faculty, topics of discussion and registration process, please visit https://www.hub-xchange.com/cns-therapeutics-xchange-east-coast-2021/#anchor1

 

Start a Conversation

uk flag+44 (0)20 7691 0984

ireland flag+353 (0)1896 42 60

poland flag+48 515 244 120

mail contact@transpharmation.co.uk


Copyright

Copyright © 2021 Transpharmation Ltd. All Rights Reserved.

Copyright © 2019 Transpharmation Ltd. All Rights Reserved. Website created by Identity Ipswich Web Design